99 related articles for article (PubMed ID: 2751317)
1. [Antitumor efficacy of FK 973 on malignant glioma cells].
Shimizu K; Yamada M; Mabuchi E; Matsui Y; Tamura K; Moriuchi S; Park K; Mogami H
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2367-72. PubMed ID: 2751317
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of a new antitumor antibiotic, FK973, in malignant glioma.
Moriuchi S; Shimizu K; Yamada M; Mabuchi E; Tamura K; Park KC; Hayakawa T
Anticancer Res; 1991; 11(6):2079-84. PubMed ID: 1776843
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor activity of FK973 for malignant gliomas and its assessment for normal brain cells].
Moriuchi S; Shimizu K; Yamada M; Mabuchi E; Tamura K; Park K; Hayakawa T; Mogami H
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2774-80. PubMed ID: 2074387
[TBL] [Abstract][Full Text] [Related]
4. [In vitro chemosensitivity test with several antitumor agents against eight malignant brain tumor cell-lines].
Mabuchi E; Shimizu K; Yamada M; Moriuchi S; Park K; Tamura K; Hayakawa T; Mogami H
Gan To Kagaku Ryoho; 1991 Feb; 18(2):233-8. PubMed ID: 1992917
[TBL] [Abstract][Full Text] [Related]
5. [MCNU effectiveness on brain tumor. Part I: Antitumor activity in vitro on human glioma and neuroblastoma cell lines].
Wakabayashi T; Yoshida J; Inoue I; Kageyama N; Nagata M; Kanzaki M
Gan To Kagaku Ryoho; 1984 May; 11(5):1098-106. PubMed ID: 6586113
[TBL] [Abstract][Full Text] [Related]
6. [Overcoming of ACNU resistance in an ACNU-resistant subline of rat C6 glioma in vivo through enhanced effect of ACNU by calmodulin inhibitor].
Yoshida T; Shimizu K; Hayakawa T; Mogami H; Sakamoto Y; Egawa T
No Shinkei Geka; 1987 Mar; 15(3):261-7. PubMed ID: 3474542
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor efficacy of recombinant interferon-beta on human glioma].
Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Tsuda N; Yamada M; Tamura K; Mogami H
Gan To Kagaku Ryoho; 1987 Feb; 14(2):490-4. PubMed ID: 3813577
[TBL] [Abstract][Full Text] [Related]
8. [Drug sensitivity test against malignant gliomas].
Nakamura O; Matsutani M; Nomura K; Takakura K
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1151-6. PubMed ID: 1693488
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
Shimomura K; Manda T; Mukumoto S; Masuda K; Nakamura T; Mizota T; Matsumoto S; Nishigaki F; Oku T; Mori J
Cancer Res; 1988 Mar; 48(5):1166-72. PubMed ID: 3342397
[TBL] [Abstract][Full Text] [Related]
10. [Chemosensitivity assays for malignant gliomas].
Sasaoka N
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2247-52. PubMed ID: 2241189
[TBL] [Abstract][Full Text] [Related]
11. [Meningeal gliomatosis model in nude mice].
Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Yoshida T; Hayakawa T; Tsuda N; Mogami H
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2600-5. PubMed ID: 3740860
[TBL] [Abstract][Full Text] [Related]
12. [Anti-tumor activity of ACNU against malignant glioma--a clinical application of in vitro sensitivity test of chemotherapeutic agent].
Shibuya N; Yoshida J; Kobayashi T; Kageyama N
No Shinkei Geka; 1983 Apr; 11(4):361-7. PubMed ID: 6306497
[TBL] [Abstract][Full Text] [Related]
13. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of single-bolus vs. frequent low-dose treatment with nitrosourea in experimental gliomas.
Wu CM; Inamura T; Ikezaki K; Nakamizo A; Inoha S; Yaosaka F; Fukui M
Anticancer Res; 2001; 21(3B):1835-8. PubMed ID: 11497267
[TBL] [Abstract][Full Text] [Related]
15. [Antitumor efficacy of activated macrophages against murine glioma cells].
Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Hayakawa T; Tsuda N; Mogami H
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2082-8. PubMed ID: 3717955
[TBL] [Abstract][Full Text] [Related]
16. [Effects of anticancer drugs on multicellular spheroid of 9L rat brain tumor].
Kohno T; Matsutani M; Hoshino T; Takakura K
No To Shinkei; 1985 Oct; 37(10):991-7. PubMed ID: 3865669
[TBL] [Abstract][Full Text] [Related]
17. [Experimental studies on the treatment of recurrent gliomas].
Yamada M; Shimizu K; Okamoto Y; Miyao Y; Matsui Y; Tsuda N; Mogami H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1890-5. PubMed ID: 3496051
[TBL] [Abstract][Full Text] [Related]
18. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
Price A; Shi Q; Morris D; Wilcox ME; Brasher PM; Rewcastle NB; Shalinsky D; Zou H; Appelt K; Johnston RN; Yong VW; Edwards D; Forsyth P
Clin Cancer Res; 1999 Apr; 5(4):845-54. PubMed ID: 10213221
[TBL] [Abstract][Full Text] [Related]
19. In vitro assessment for neurotoxicity of antitumor agents before local administration into central nervous system.
Moriuchi S; Shimizu K; Miyao Y; Yamada M; Ohkawa M; Hayakawa T
Anticancer Res; 1996; 16(1):135-40. PubMed ID: 8615598
[TBL] [Abstract][Full Text] [Related]
20. [Response to antitumor agents of human transplantable glioma implanted into chorioallantoic membrane of chick embryo].
Nakamura O; Sasaki T; Uchida H; Tanaka M; Endo Y; Nishikawa K; Matsutani M; Takakura K
No Shinkei Geka; 1988 Apr; 16(4):353-7. PubMed ID: 3164446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
